Our Mission: More life for people with cancer
Our work doesn’t stop when the research is done or the discovery is made. The burden of cancer is vast, but so are our aspirations to redefine how this disease is treated.
BY THE NUMBERS
Events & Conferences
ASH 2023 Investor Event with Medical Experts
The event will highlight pelabresib’s potential in first-line myelofibrosis with a comprehensive overview of the Phase 3 MANIFEST-2 trial results, which will be presented during an oral presentation at ASH 2023 on Sunday December 10. There will be live presentations from and a Q&A opportunity with MorphoSys management and leading medical experts.
Monday, December 11, 7:00 a.m. – 8:30 a.m. PST (10:00 a.m. - 11:30 a.m. EST / 4:00 p.m. - 5:30 p.m. CET)